NO169638C - Formuleringsblanding med stabiliserende virkning paa alfa-interferon - Google Patents
Formuleringsblanding med stabiliserende virkning paa alfa-interferonInfo
- Publication number
- NO169638C NO169638C NO870441A NO870441A NO169638C NO 169638 C NO169638 C NO 169638C NO 870441 A NO870441 A NO 870441A NO 870441 A NO870441 A NO 870441A NO 169638 C NO169638 C NO 169638C
- Authority
- NO
- Norway
- Prior art keywords
- active ingredient
- stabilizing effect
- formulation mixture
- alfa interferon
- ifn alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863603444 DE3603444A1 (de) | 1986-02-05 | 1986-02-05 | Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO870441D0 NO870441D0 (no) | 1987-02-04 |
| NO870441L NO870441L (no) | 1987-08-06 |
| NO169638B NO169638B (no) | 1992-04-13 |
| NO169638C true NO169638C (no) | 1992-07-22 |
Family
ID=6293372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO870441A NO169638C (no) | 1986-02-05 | 1987-02-04 | Formuleringsblanding med stabiliserende virkning paa alfa-interferon |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0231816B1 (no) |
| JP (1) | JPS62209024A (no) |
| KR (1) | KR870007698A (no) |
| AT (1) | ATE63823T1 (no) |
| AU (1) | AU601712B2 (no) |
| CA (1) | CA1295242C (no) |
| DD (1) | DD284602A5 (no) |
| DE (2) | DE3603444A1 (no) |
| DK (1) | DK164202C (no) |
| ES (1) | ES2028796T3 (no) |
| FI (1) | FI86144C (no) |
| GR (1) | GR3002270T3 (no) |
| HU (1) | HU196560B (no) |
| IE (1) | IE59697B1 (no) |
| IL (1) | IL81472A0 (no) |
| NO (1) | NO169638C (no) |
| NZ (1) | NZ219169A (no) |
| PH (1) | PH24377A (no) |
| PT (1) | PT84243B (no) |
| ZA (1) | ZA87793B (no) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5275804A (en) * | 1986-02-25 | 1994-01-04 | E. B. Michaels Research Associates, Inc. | Process and composition for oral hygiene |
| US5266310A (en) * | 1987-09-17 | 1993-11-30 | Boehringer Ingelheim International Gmbh | Stabilization of therapeutically active proteins in pharmaceutical preparations |
| DE3731255A1 (de) * | 1987-09-17 | 1989-04-06 | Boehringer Ingelheim Int | Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen |
| DE3803312A1 (de) * | 1988-02-04 | 1989-08-10 | Gerd Prof Dr Med Gross | Verwendung eines interferonenthaltenden gels |
| NO179479C (no) * | 1988-03-11 | 1996-10-16 | Teikoku Seiyaku Kk | Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat |
| ATE110571T1 (de) * | 1988-05-06 | 1994-09-15 | Toray Industries | Stabile interferon-beta-zusammensetzung. |
| US5389676A (en) * | 1991-03-22 | 1995-02-14 | E. B. Michaels Research Associates, Inc. | Viscous surfactant emulsion compositions |
| US5244652A (en) * | 1991-03-22 | 1993-09-14 | E. B. Michaels Research Associates, Inc. | Viscous surface active composition |
| JPH07501320A (ja) * | 1991-10-11 | 1995-02-09 | ギリーズ，マーク・セドリック | インタ−フェロン・アルファによる眼線維症の治療 |
| US5863530A (en) * | 1991-10-11 | 1999-01-26 | Spruson & Ferguson | Treating ophthalmic fibrosis using interferon-α |
| US6630168B1 (en) * | 1997-02-20 | 2003-10-07 | Biomedicines, Inc. | Gel delivery vehicles for anticellular proliferative agents |
| FI106465B (fi) * | 1998-06-10 | 2001-02-15 | Suomen Punainen Risti Veripalv | Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi |
| US6923966B2 (en) | 1999-04-08 | 2005-08-02 | Schering Corporation | Melanoma therapy |
| JP4536194B2 (ja) * | 2000-02-17 | 2010-09-01 | 大日本住友製薬株式会社 | 安定な注射用製剤 |
| PL202918B1 (pl) * | 2000-03-07 | 2009-08-31 | Rush Presbyterian St Luke | Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie |
| US6328987B1 (en) * | 2000-11-03 | 2001-12-11 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions containing alpha interferon |
| RU2004116692A (ru) * | 2001-11-02 | 2005-03-20 | Секисуй Кемикал Ко., Лтд. (Jp) | Индуцирующее цитокины вещество и устройство для индукции цитокинов |
| US8137677B2 (en) * | 2005-10-06 | 2012-03-20 | Allergan, Inc. | Non-protein stabilized clostridial toxin pharmaceutical compositions |
| SG176254A1 (en) * | 2009-05-29 | 2011-12-29 | Filligent Ltd | Composition for use in decreasing the transmission of human pathogens |
| BR112014021653B1 (pt) | 2012-03-01 | 2023-03-28 | Firststring Research, Inc. | Formulação tópica, uso da formulação tópica e método para fabricar uma formulação tópica |
| JP6081156B2 (ja) * | 2012-11-15 | 2017-02-15 | アルケア株式会社 | ハイドロゲル |
| DE102012222365A1 (de) | 2012-12-05 | 2014-06-05 | Aesculap Ag | Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen |
| CN105530950A (zh) * | 2013-06-09 | 2016-04-27 | 艾弗兰纳特有限公司 | 包含Gc-巨噬细胞活化因子的组合物及其用途 |
| BR112019013612B1 (pt) | 2017-01-31 | 2022-08-09 | Kimberly-Clark Worldwide, Inc | Método para inibir o crescimento bacteriano em um produto, composição antibacteriana, e, lenço. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1234383A (en) * | 1982-03-17 | 1983-09-22 | Inter-Yeda Ltd. | Interferon stabilised with polyvinyl-pyrrolidone |
| JPS6061535A (ja) * | 1983-08-24 | 1985-04-09 | エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト | 製薬学的組成物 |
| JPS6069037A (ja) * | 1983-09-26 | 1985-04-19 | Sunstar Inc | エリテマト−デス治療用外用剤 |
| DE3484951D1 (de) * | 1983-10-14 | 1991-09-26 | Sumitomo Pharma | Verlaengerte praeparate mit verzoegerter abgabe. |
| US4680175A (en) * | 1984-02-07 | 1987-07-14 | Interferon Sciences, Inc. | Interferon administration vehicles |
| CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
| JPS60228422A (ja) * | 1984-04-26 | 1985-11-13 | Suntory Ltd | 安定化された生理活性物質製剤 |
| JPS60260523A (ja) * | 1984-06-07 | 1985-12-23 | Asahi Chem Ind Co Ltd | インタ−フエロンの凍結乾燥医薬組成物 |
-
1986
- 1986-02-05 DE DE19863603444 patent/DE3603444A1/de not_active Withdrawn
-
1987
- 1987-01-21 ES ES198787100792T patent/ES2028796T3/es not_active Expired - Lifetime
- 1987-01-21 AT AT87100792T patent/ATE63823T1/de not_active IP Right Cessation
- 1987-01-21 EP EP87100792A patent/EP0231816B1/de not_active Expired - Lifetime
- 1987-01-21 DE DE8787100792T patent/DE3770280D1/de not_active Expired - Fee Related
- 1987-02-03 FI FI870457A patent/FI86144C/fi not_active IP Right Cessation
- 1987-02-03 DD DD87299676A patent/DD284602A5/de not_active IP Right Cessation
- 1987-02-03 CA CA000528832A patent/CA1295242C/en not_active Expired - Lifetime
- 1987-02-04 JP JP62024423A patent/JPS62209024A/ja active Pending
- 1987-02-04 NZ NZ219169A patent/NZ219169A/en unknown
- 1987-02-04 PT PT84243A patent/PT84243B/pt not_active IP Right Cessation
- 1987-02-04 ZA ZA87793A patent/ZA87793B/xx unknown
- 1987-02-04 HU HU87385A patent/HU196560B/hu not_active IP Right Cessation
- 1987-02-04 IL IL81472A patent/IL81472A0/xx not_active IP Right Cessation
- 1987-02-04 DK DK058387A patent/DK164202C/da not_active IP Right Cessation
- 1987-02-04 AU AU68292/87A patent/AU601712B2/en not_active Ceased
- 1987-02-04 IE IE29587A patent/IE59697B1/en not_active IP Right Cessation
- 1987-02-04 NO NO870441A patent/NO169638C/no unknown
- 1987-02-05 KR KR870000912A patent/KR870007698A/ko not_active Application Discontinuation
- 1987-02-05 PH PH34815A patent/PH24377A/en unknown
-
1991
- 1991-07-08 GR GR91400966T patent/GR3002270T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL81472A0 (en) | 1987-09-16 |
| PT84243B (pt) | 1989-09-14 |
| NO870441D0 (no) | 1987-02-04 |
| IE59697B1 (en) | 1994-03-23 |
| ZA87793B (en) | 1988-10-26 |
| NO870441L (no) | 1987-08-06 |
| ES2028796T3 (es) | 1992-07-16 |
| DD284602A5 (de) | 1990-11-21 |
| AU6829287A (en) | 1987-08-06 |
| FI870457A (fi) | 1987-08-06 |
| FI86144B (fi) | 1992-04-15 |
| DK164202C (da) | 1992-10-19 |
| GR3002270T3 (en) | 1992-12-30 |
| DK58387A (da) | 1987-08-06 |
| HUT43494A (en) | 1987-11-30 |
| ATE63823T1 (de) | 1991-06-15 |
| JPS62209024A (ja) | 1987-09-14 |
| EP0231816A3 (en) | 1987-09-23 |
| CA1295242C (en) | 1992-02-04 |
| DK58387D0 (da) | 1987-02-04 |
| PH24377A (en) | 1990-06-13 |
| FI870457A0 (fi) | 1987-02-03 |
| FI86144C (fi) | 1992-07-27 |
| IE870295L (en) | 1987-08-05 |
| AU601712B2 (en) | 1990-09-20 |
| KR870007698A (ko) | 1987-09-21 |
| DE3770280D1 (de) | 1991-07-04 |
| PT84243A (de) | 1987-03-01 |
| EP0231816A2 (de) | 1987-08-12 |
| NZ219169A (en) | 1990-04-26 |
| DK164202B (da) | 1992-05-25 |
| NO169638B (no) | 1992-04-13 |
| EP0231816B1 (de) | 1991-05-29 |
| HU196560B (en) | 1988-12-28 |
| DE3603444A1 (de) | 1987-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO169638C (no) | Formuleringsblanding med stabiliserende virkning paa alfa-interferon | |
| DK203787D0 (da) | Praeparat til nasal administrering | |
| DE3581819D1 (de) | Pyridazinamine wirksam gegen viren. | |
| IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
| DE69325236D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Urodeoxycholicsäure | |
| DK305087A (da) | Buprenorphinholdigt farmaceutisk suppositorium | |
| DK396286A (da) | Injicerbar formulering med forsinket frigivelse af den aktive bestanddel | |
| NO863027L (no) | Peptidpreparater med kontinuerlig avgivelse. | |
| DK516288D0 (da) | Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater | |
| ATE27813T1 (de) | N-substituierte 1-(4'-alkylsulfonylphenyl)-2amino-1,3-propanediol-derivate. | |
| DE68906572D1 (de) | Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| GB1351437A (en) | N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity | |
| ES2016052A6 (es) | Procedimiento para preparar derivados de adenosinmonofosfonato (amp) ciclico y de guanosinmonofosfonato (gmp) ciclico. | |
| DK0578535T3 (da) | Hidtil ukendt peptid-derivater, der er aktive i celleadhæsionsprocesser, fremgangsmåde til deres fremstilling samt farmaceutiske sammensætninger indeholdende derivarerne | |
| IT1216103B (it) | Peptidi ad attivita' farmaceutica. |